- Home
- VERV vs GRC Comparison
VERV vs GRC Comparison
Compare VERV & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- GRC
- Stock Information
- Founded
- VERV 2018
- GRC 1933
- Country
- VERV United States
- GRC United States
- Employees
- VERV N/A
- GRC N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- GRC Fluid Controls
- Sector
- VERV Health Care
- GRC Industrials
- Exchange
- VERV Nasdaq
- GRC Nasdaq
- Market Cap
- VERV 1.0B
- GRC 1.0B
- IPO Year
- VERV 2021
- GRC N/A
- Fundamental
- Price
- VERV $11.06
- GRC $37.39
- Analyst Decision
- VERV Buy
- GRC
- Analyst Count
- VERV 11
- GRC 0
- Target Price
- VERV $14.57
- GRC N/A
- AVG Volume (30 Days)
- VERV 7.6M
- GRC 54.6K
- Earning Date
- VERV 08-07-2025
- GRC 07-25-2025
- Dividend Yield
- VERV N/A
- GRC 1.94%
- EPS Growth
- VERV N/A
- GRC 21.97
- EPS
- VERV N/A
- GRC 1.69
- Revenue
- VERV $59,613,000.00
- GRC $664,347,000.00
- Revenue This Year
- VERV $47.32
- GRC $4.50
- Revenue Next Year
- VERV N/A
- GRC $4.50
- P/E Ratio
- VERV N/A
- GRC $22.58
- Revenue Growth
- VERV 271.44
- GRC 0.92
- 52 Week Low
- VERV $2.87
- GRC $30.87
- 52 Week High
- VERV $11.41
- GRC $43.79
- Technical
- Relative Strength Index (RSI)
- VERV 78.23
- GRC 51.75
- Support Level
- VERV $11.16
- GRC $37.75
- Resistance Level
- VERV $11.30
- GRC $38.53
- Average True Range (ATR)
- VERV 0.12
- GRC 0.78
- MACD
- VERV -0.18
- GRC 0.11
- Stochastic Oscillator
- VERV 12.50
- GRC 62.12
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.